Tebipenem-pivoxil-hydrobromide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tebipenem-pivoxil-hydrobromide, covering 2025-05-20 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]